Treating psoriasis with biologic drugs that target the immune system can reduce early plaque build-up, which clogs arteries, restricts blood flow, and can lead to heart attacks and stroke. By extrapolation, this might also be beneficial to patients with chronic atopic dermatitis.
The association between psoriasis and occlusive cardiovascular events was noted originally nearly 50 years ago , and it is generally attributed to the heightened systematic inflammation present in psoriasis patients, which results in excess low-density lipoproteins lining the arteries. What was not yet known was whether modulating the inflammatory condition with immunotherapy would result in reduced risk of cardiovascular disease.
Dr Nehal Mehta (National Heart, Lung, and Blood Institute, NIH, USA) presented the just-published results of the first in-human evidence that treating psoriasis patients with biologic systemic therapies has positive consequences on cardiovascul...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Atopic dermatitis and psoriasis: on a spectrum? Next Article
Certolizumab: Long-term safety and efficacy results for psoriasis-related nail disease »
Table of Contents: SPIN 2019
Aetiology: Triggers and Risk Factors
Advances in Therapy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.